476 related articles for article (PubMed ID: 16633377)
1. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
Das D; Khan M; Gul A; Alam R
J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
Nicoară S
Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
[TBL] [Abstract][Full Text] [Related]
6. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
Uchio E; Itoh Y; Kadonosono K
Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
[TBL] [Abstract][Full Text] [Related]
7. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G
Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
Santos CI; Huang AJ; Abelson MB; Foster CS; Friedlaender M; McCulley JP
Am J Ophthalmol; 1994 Apr; 117(4):488-97. PubMed ID: 8154531
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
[TBL] [Abstract][Full Text] [Related]
11. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
[TBL] [Abstract][Full Text] [Related]
13. [An efficacy study of lodoxamide treatment in allergic eye lesions].
Giuri S; Munteanu GH
Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
[TBL] [Abstract][Full Text] [Related]
16. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
Oguz H; Bitiren M; Aslan OS; Ozardali I
Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
Greiner JV; Udell IJ
Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
[TBL] [Abstract][Full Text] [Related]
20. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
